Dedicare (DEDI) Q2 2026 earnings summary

Executive summary

• Net sales increased by 10.0% year-over-year in Q2 2026 to SEK 387.0 million, with organic growth of 5.3%.

• Profitability improved, with EBITA up 49.2% to SEK 19.4 million and EBITA margin rising to 5.0%.

• Growth was driven by stable market conditions, rationalisation, and the WeCare acquisition.

• Sweden and Denmark showed strong growth, while Norway remained stable and the UK faced challenges.

Financial highlights

• Q2 2026 EBITA: SEK 19.4 million (up from SEK 13.0 million); EBITA margin: 5.0% (3.7%).

• Profit after financial items: SEK 17.7 million (11.7); net profit: SEK 13.6 million (9.1).

• Basic/diluted EPS: SEK 1.42 (0.95).

• H1 2026 net sales: SEK 750.2 million (703.1); EBITA: SEK 28.7 million (23.5); EBITA margin: 3.8% (3.3%).

• Cash flow from operating activities in Q2: SEK -29.2 million (-33.3); cash and cash equivalents at period end: SEK 70.3 million (95.0).

Outlook and guidance

• Market conditions are stabilising, but remain complex with differences across countries and segments.

• Continued focus on broadening the business base, efficiency, and developing new revenue streams.

• No significant events after the quarter; positive outlook for ongoing progress.